Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults

Swapnil N. Rajpathak, Aileen P. McGinn, Howard Strickler, Thomas E. Rohan, Michael Pollak, Anne R. Cappola, Lewis Kuller, Xiaonan (Nan) Xue, Anne B. Newman, Elsa S. Strotmeyer, Bruce M. Psaty, Robert C. Kaplan

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Increasing evidence suggests that the insulin-like growth factor (IGF)-axis may play a role in glucose metabolism and may also be associated with systemic inflammation. The aim of this study was to evaluate the association of insulin-like growth factor-1 (IGF-I) and its binding proteins, IGFBP-1 and IGFBP-3, with glucose intolerance and inflammation among older adults. We conducted a cross-sectional analysis in a in a random subsample (n = 922) of the Cardiovascular Health Study (CHS), a prospective cohort of men and women ≥65 years. Mean IGFBP-1 levels were significantly lower in older adults with impaired glucose tolerance (IGT), impaired fasting glucose (IFG) and diabetes compared to those with normal fasting and post-load glucose. High IGFBP-1 was associated with a reduced prevalence of IGT and IFG; the multivariable OR between extreme quartiles of IGFBP-1 was 0.60 (95% CI: 0.37, 0.95; p-trend: 0.03) for IGT and 0.41 (95% CI: 0.26, 0.64; p-trend: <0.01) for IFG. We did not find any significant association between IGF-I and glucose intolerance in this study and the association for IGFBP-3 was less clear. However, low levels of IGF-I and IGFBP-3 were associated with increased levels of markers of inflammation including C-reactive protein and interleukin-6 levels. We conclude that among adults ≥65 years, low IGFBP-1 levels are associated with increased prevalence of glucose intolerance. We did not confirm prior associations of low IGF-I with glucose intolerance in this cohort of older individuals.

Original languageEnglish (US)
Pages (from-to)166-173
Number of pages8
JournalGrowth Hormone and IGF Research
Volume18
Issue number2
DOIs
StatePublished - Apr 2008

Fingerprint

Glucose Intolerance
Somatomedins
Insulin-Like Growth Factor Binding Protein 1
Inflammation
Insulin-Like Growth Factor I
Insulin-Like Growth Factor Binding Protein 3
Fasting
Glucose
C-Reactive Protein
Interleukin-6
Carrier Proteins
Cross-Sectional Studies
Prospective Studies
Health

Keywords

  • Glucose intolerance
  • IGF-I
  • IGFBP-I
  • Inflammation

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults. / Rajpathak, Swapnil N.; McGinn, Aileen P.; Strickler, Howard; Rohan, Thomas E.; Pollak, Michael; Cappola, Anne R.; Kuller, Lewis; Xue, Xiaonan (Nan); Newman, Anne B.; Strotmeyer, Elsa S.; Psaty, Bruce M.; Kaplan, Robert C.

In: Growth Hormone and IGF Research, Vol. 18, No. 2, 04.2008, p. 166-173.

Research output: Contribution to journalArticle

Rajpathak, Swapnil N. ; McGinn, Aileen P. ; Strickler, Howard ; Rohan, Thomas E. ; Pollak, Michael ; Cappola, Anne R. ; Kuller, Lewis ; Xue, Xiaonan (Nan) ; Newman, Anne B. ; Strotmeyer, Elsa S. ; Psaty, Bruce M. ; Kaplan, Robert C. / Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults. In: Growth Hormone and IGF Research. 2008 ; Vol. 18, No. 2. pp. 166-173.
@article{2c0f292920c44161bbd39ae7abc7e143,
title = "Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults",
abstract = "Increasing evidence suggests that the insulin-like growth factor (IGF)-axis may play a role in glucose metabolism and may also be associated with systemic inflammation. The aim of this study was to evaluate the association of insulin-like growth factor-1 (IGF-I) and its binding proteins, IGFBP-1 and IGFBP-3, with glucose intolerance and inflammation among older adults. We conducted a cross-sectional analysis in a in a random subsample (n = 922) of the Cardiovascular Health Study (CHS), a prospective cohort of men and women ≥65 years. Mean IGFBP-1 levels were significantly lower in older adults with impaired glucose tolerance (IGT), impaired fasting glucose (IFG) and diabetes compared to those with normal fasting and post-load glucose. High IGFBP-1 was associated with a reduced prevalence of IGT and IFG; the multivariable OR between extreme quartiles of IGFBP-1 was 0.60 (95{\%} CI: 0.37, 0.95; p-trend: 0.03) for IGT and 0.41 (95{\%} CI: 0.26, 0.64; p-trend: <0.01) for IFG. We did not find any significant association between IGF-I and glucose intolerance in this study and the association for IGFBP-3 was less clear. However, low levels of IGF-I and IGFBP-3 were associated with increased levels of markers of inflammation including C-reactive protein and interleukin-6 levels. We conclude that among adults ≥65 years, low IGFBP-1 levels are associated with increased prevalence of glucose intolerance. We did not confirm prior associations of low IGF-I with glucose intolerance in this cohort of older individuals.",
keywords = "Glucose intolerance, IGF-I, IGFBP-I, Inflammation",
author = "Rajpathak, {Swapnil N.} and McGinn, {Aileen P.} and Howard Strickler and Rohan, {Thomas E.} and Michael Pollak and Cappola, {Anne R.} and Lewis Kuller and Xue, {Xiaonan (Nan)} and Newman, {Anne B.} and Strotmeyer, {Elsa S.} and Psaty, {Bruce M.} and Kaplan, {Robert C.}",
year = "2008",
month = "4",
doi = "10.1016/j.ghir.2007.08.004",
language = "English (US)",
volume = "18",
pages = "166--173",
journal = "Endocrinology and Metabolism",
issn = "1096-6374",
publisher = "Churchill Livingstone",
number = "2",

}

TY - JOUR

T1 - Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults

AU - Rajpathak, Swapnil N.

AU - McGinn, Aileen P.

AU - Strickler, Howard

AU - Rohan, Thomas E.

AU - Pollak, Michael

AU - Cappola, Anne R.

AU - Kuller, Lewis

AU - Xue, Xiaonan (Nan)

AU - Newman, Anne B.

AU - Strotmeyer, Elsa S.

AU - Psaty, Bruce M.

AU - Kaplan, Robert C.

PY - 2008/4

Y1 - 2008/4

N2 - Increasing evidence suggests that the insulin-like growth factor (IGF)-axis may play a role in glucose metabolism and may also be associated with systemic inflammation. The aim of this study was to evaluate the association of insulin-like growth factor-1 (IGF-I) and its binding proteins, IGFBP-1 and IGFBP-3, with glucose intolerance and inflammation among older adults. We conducted a cross-sectional analysis in a in a random subsample (n = 922) of the Cardiovascular Health Study (CHS), a prospective cohort of men and women ≥65 years. Mean IGFBP-1 levels were significantly lower in older adults with impaired glucose tolerance (IGT), impaired fasting glucose (IFG) and diabetes compared to those with normal fasting and post-load glucose. High IGFBP-1 was associated with a reduced prevalence of IGT and IFG; the multivariable OR between extreme quartiles of IGFBP-1 was 0.60 (95% CI: 0.37, 0.95; p-trend: 0.03) for IGT and 0.41 (95% CI: 0.26, 0.64; p-trend: <0.01) for IFG. We did not find any significant association between IGF-I and glucose intolerance in this study and the association for IGFBP-3 was less clear. However, low levels of IGF-I and IGFBP-3 were associated with increased levels of markers of inflammation including C-reactive protein and interleukin-6 levels. We conclude that among adults ≥65 years, low IGFBP-1 levels are associated with increased prevalence of glucose intolerance. We did not confirm prior associations of low IGF-I with glucose intolerance in this cohort of older individuals.

AB - Increasing evidence suggests that the insulin-like growth factor (IGF)-axis may play a role in glucose metabolism and may also be associated with systemic inflammation. The aim of this study was to evaluate the association of insulin-like growth factor-1 (IGF-I) and its binding proteins, IGFBP-1 and IGFBP-3, with glucose intolerance and inflammation among older adults. We conducted a cross-sectional analysis in a in a random subsample (n = 922) of the Cardiovascular Health Study (CHS), a prospective cohort of men and women ≥65 years. Mean IGFBP-1 levels were significantly lower in older adults with impaired glucose tolerance (IGT), impaired fasting glucose (IFG) and diabetes compared to those with normal fasting and post-load glucose. High IGFBP-1 was associated with a reduced prevalence of IGT and IFG; the multivariable OR between extreme quartiles of IGFBP-1 was 0.60 (95% CI: 0.37, 0.95; p-trend: 0.03) for IGT and 0.41 (95% CI: 0.26, 0.64; p-trend: <0.01) for IFG. We did not find any significant association between IGF-I and glucose intolerance in this study and the association for IGFBP-3 was less clear. However, low levels of IGF-I and IGFBP-3 were associated with increased levels of markers of inflammation including C-reactive protein and interleukin-6 levels. We conclude that among adults ≥65 years, low IGFBP-1 levels are associated with increased prevalence of glucose intolerance. We did not confirm prior associations of low IGF-I with glucose intolerance in this cohort of older individuals.

KW - Glucose intolerance

KW - IGF-I

KW - IGFBP-I

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=39749087521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39749087521&partnerID=8YFLogxK

U2 - 10.1016/j.ghir.2007.08.004

DO - 10.1016/j.ghir.2007.08.004

M3 - Article

VL - 18

SP - 166

EP - 173

JO - Endocrinology and Metabolism

JF - Endocrinology and Metabolism

SN - 1096-6374

IS - 2

ER -